D. Kern

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Don Kern, Donald E Kern, Donald E. Kern, D. E. Kern, D Kern, D E Kern
Publication record
35 papers · 2,360 citations · H-index 17

PAPERS

Adoptive Transfer of T Cells for Therapy of Disseminated Leukemia: Antigen Specificity And Function of Tumor-Reactive T Cells
20180 citationsauthor #2
Analysis of T-cell receptor gene rearrangement in lymph nodes of patients with mycosis fungoides. Prognostic implications.
199844 citationsauthor #1
The repertoire of T cell antigen receptor beta-chain variable regions associated with psoriasis vulgaris.
199730 citationsauthor #7
Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients.
199018 citationsauthor #6
Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells.
19900 citationsauthor #1
Helper-independent CD8+ cytotoxic T lymphocytes express IL-1 receptors and require IL-1 for secretion of IL-2.
198939 citationsauthor #2
Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.
19894 citationsauthor #1
FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens
198982 citationsauthor #1
Induction of lymphokine-activated killer activity by interleukin 4 in human lymphocytes preactivated by interleukin 2 in vivo or in vitro.
198933 citationsauthor #6
Specific adoptive immunotherapy.
19893 citationsauthor #3
Requirements for T cell recognition and elimination of retrovirally-transformed cells.
198812 citationsauthor #3
IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
198852 citationsauthor #2
Il-4 is an endogenous T cell growth factor during the immune response to a syngeneic retrovirus-induced tumor.
198810 citationsauthor #1
Therapy of disseminated tumors by adoptive transfer of specifically immune T cells.
198838 citationsauthor #3
Specific Adoptive Therapy of Disseminated Tumors
19870 citationsauthor #3
Specific Adoptive Therapy of Disseminated Tumors Requirements for Therapeutic Efficacy and Mechanisms by Which T Cells Mediate Tumor Eradication
19870 citationsauthor #2
Effector mechanisms by which adoptively transferred T cells promote tumor eradication.
19879 citationsauthor #2
Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory.
198748 citationsauthor #3
Lyt-2+ cells. Requirements for concanavalin A-induced proliferation and interleukin 2 production.
198717 citationsauthor #1
Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
198693 citationsauthor #1
Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2.
1986110 citationsauthor #4
Identification of a macrophage activation factor (MAF) distinct from gamma interferon (. gamma. IF) which induces macrophage cytotoxicity
19860 citationsauthor #1
Interleukin 2 (IL 2) administered in vivo: influence of IL 2 route and timing on T cell growth.
198590 citationsauthor #3
Class II-restricted T cells and I-A+ accessory cells are required for the in vitro generation of optimal CTL activity against a class II negative tumor cell line
19850 citationsauthor #2
Generation of lymphokine-activated killer (LAK) activity in vivo with recombinant interleukin 2
19851 citationsauthor #3
Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells
1985320 citationsauthor #2
T cell recognition of MHC determinants is required for Con A-induced activation
19850 citationsauthor #1
Interleukin-2 administered in vivo induces the growth and augments the function of cultured T cells in vivo.
19846 citationsauthor #3
INTERLEUKIN-2 AND THE REGULATION OF CYTOTOXIC CELLS
19830 citationsauthor #2
Cytotoxic responses: the regulatory influence of interleukin-2.
19828 citationsauthor #2
Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity.
1981313 citationsauthor #3
Interleukin-2 augments natural killer cell activity
1981878 citationsauthor #3
Relationship between in vivo mitomycin C exposure, sister chromatid exchange induction and in vitro mitogenic proliferation. II. Effect of aging on spleen cell mitogenesis and sister chromatid exchange induction.
19812 citationsauthor #2
The role of interleukin-2 (IL-2) in the differentiatin of cytotoxic T cells: the effect of monoclonal anti-IL-2 antibody and absorption with IL-2 dependent T cell lines.
198199 citationsauthor #1
Relationship between in vivo mitomycin C exposure, sister chromatid exchange induction and in vitro mitogenic proliferation. I. Development of murine splenic cell system.
19811 citationsauthor #2

TIMELINE

1981 1,293 citations

1982 8 citations

1983 0 citations

1984 6 citations

1985 411 citations

1986 203 citations

1987 74 citations

1988 112 citations

1989 161 citations

1990 18 citations

1997 30 citations

1998 44 citations

2018 0 citations

D. Kern

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT